Pathological perspectives in pilocytic astrocytomas: Extent of resection as the sole critical factor for recurrence-free survival, and the challenge of evaluating conclusions derived from limited data

Authors

  • Ibrahim Kulac Department of Pathology, Koc University School of Medicine, Istanbul, Turkey https://orcid.org/0000-0003-2003-7567
  • Irem Yenidogan Department of Pediatrics, Koc University School of Medicine, Istanbul, Turkey
  • Banu Oflaz Sozmen Department of Pediatrics, Koc University School of Medicine, Istanbul, Turkey; Division of Pediatric Hematology and Oncology, Koc University School of Medicine, Istanbul, Turkey
  • Arzu Baygul Department of Biostatistics, Koc University School of Medicine, Istanbul, Turkey
  • Soonmee Cha Department of Radiology, University of California, San Francisco, CA, USA
  • Melike Pekmezci Department of Pathology, University of California, San Francisco, CA, USA
  • Tarik Tihan Department of Pathology, University of California, San Francisco, CA, USA

DOI:

https://doi.org/10.17879/freeneuropathology-2023-5116

Keywords:

Astrocytoma, Entity, Circumscribed gliomas, Glioma, Juvenile pilocytic astrocytoma, Pilocytic astrocytoma, Piloid, Pilomyxoid, Tumor type

Abstract

Introduction: Pilocytic astrocytoma (PA) is one of the most common primary intracranial neoplasms in childhood with an overall favorable prognosis. Despite decades of experience, there are still diagnostic and treatment challenges and unresolved issues regarding risk factors associated with recurrence, most often due to conclusions of publications with limited data. We analyzed 499 patients with PA diagnosed in a single institution over 30 years in order to provide answers to some of the unresolved issues.

Materials and Methods: We identified pilocytic astrocytomas diagnosed at the University of California, San Francisco, between 1989 and 2019, confirmed the diagnoses using the WHO 2021 essential and desirable criteria, and performed a retrospective review of the demographic and clinical features of the patients and the radiological, pathologic and molecular features of the tumors.

Results: Among the patients identified from pathology archives, 499 cases fulfilled the inclusion criteria. Median age at presentation was 12 years (range 3.5 months – 73 years) and the median follow-up was 78.5 months. Tumors were predominantly located in the posterior fossa (52.6%). There were six deaths, but there were confounding factors that prevented a clear association of death to tumor progression. Extent of resection was the only significant factor for recurrence-free survival. Recurrence-free survival time was 321.0 months for gross total resection, compared to 160.9 months for subtotal resection (log rank, p <0.001).

Conclusion: Multivariate analysis was able to identify extent of resection as the only significant variable to influence recurrence-free survival. We did not find a statistically significant association between age, NF1 status, tumor location, molecular alterations, and outcome. Smaller series with apparently significant results may have suffered from limited sample size, limited variables, acceptance of univariate analysis findings as well as a larger p value for biological significance. PA still remains a predominantly surgical disease and every attempt should be made to achieve gross total resection since this appears to be the most reliable predictor of recurrence-free survival.

Metrics

Metrics Loading ...

Downloads

Published

2023-10-20

How to Cite

Kulac, I., Yenidogan, I., Oflaz Sozmen, B., Baygul, A., Cha, S., Pekmezci, M., & Tihan, T. (2023). Pathological perspectives in pilocytic astrocytomas: Extent of resection as the sole critical factor for recurrence-free survival, and the challenge of evaluating conclusions derived from limited data. Free Neuropathology, 4, 17. https://doi.org/10.17879/freeneuropathology-2023-5116

Issue

Section

Original Papers